DocDollars

Nevro Corp.

CA · United States · Reporting entity ID 100000136428

Total reported 2019–2025
$31.1M
#231 of 2,960 reporting companies — 0% of all reported industry payments
$14.5M in general payments across 161,789 records, plus $16.6M in research funding across 2,582 records.

How it breaks down

General payments $14,501,428
Research funding $16,617,465

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Nevro Corp. reported $31.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #231 of 2,960 reporting companies. 53% of that was research funding and 47% general payments such as consulting, speaking, food and travel. 161,789 general payment records and 2,582 research records were filed.

Common questions about Nevro Corp.

How much has Nevro Corp. paid US doctors?

Nevro Corp. reported $31,118,894 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $14,501,428 in general payments, $16,617,465 in research funding.

How does Nevro Corp. rank among drug and device companies?

It ranks #231 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Nevro Corp. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.